Last updated on October 2018

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease


Brief description of study

The purpose of this study is to evaluate the pharmacokinetics (PK) of ustekinumab in subjects from 2 through less than (<) 18 years old in the USA, or 6 through less than (<) 18 years old in other countries and determine if it is similar to that observed in adults with moderately to severely active Crohn's disease (CD). Also to assess the safety, immunogenicity and efficacy of ustekinumab in the treatment of moderately to severely active CD. The main part of the study continues to Week 16, at which point all subjects who are receiving benefit from ustekinumab maintenance therapy (as determined by the investigator) are eligible to enter the long-term extension (LTE) and continue to receive ustekinumab. The study extension ends at Week 236.

Clinical Study Identifier: NCT02968108

Contact Investigators or Research Sites near you

Start Over

Study Contact

Phoenix Children's Hospital
Phoenix, AZ United States

Study Contact

Cedars-Sinai Medical Center
Los Angeles, CA United States

Study Contact

Connecticut Childrens Medical Center
Hartford, CT United States

Study Contact

Emory University
Atlanta, GA United States

Study Contact

Children's Center For Digestive Healthcare, Llc
Atlanta, GA United States

Study Contact

Methodist Medical Center of Illinois
Peoria, IL United States

Study Contact

Mayo Clinic
Rochester, MN United States

Study Contact

Mount Sinai
New York, NY United States

Study Contact

Childrens Hospital Of Philadelphia
Philadelphia, PA United States

Study Contact

Center For Digestive Health Systems-Greenville
Greenville, SC United States

Study Contact

Medical College Of Wisconsin
Milwaukee, WI United States

Study Contact

Universitair Kinderziekenhuis Koningin Fabiola
Brussel, Belgium

Study Contact

Cliniques Universitaires Saint-Luc
Brussel, Belgium

Study Contact

UZ Gent
Gent, Belgium

Study Contact

UZ Brussel
Jette, Belgium

Study Contact

UZ Leuven
Leuven, Belgium

Study Contact

Stollery Children's Hospital
Edmonton, AB Canada

Study Contact

British Columbia Children's Hospital
Vancouver, BC Canada

Study Contact

Children's Hospital of Western Ontario
London, ON Canada

Study Contact

Hospital For Sick Children
Toronto, ON Canada

Study Contact

Centre Hospitalier Sainte Justine
Montreal, QC Canada

Study Contact

H pital Jeanne de FLANDRE, CHRU LILLE
Lille, France

Study Contact

H pital Necker
Paris, France

Study Contact

H pital Robert Debr
Paris, France

Study Contact

Dr. von Haunersches Kinderspital
Munich, Germany

Study Contact

HELIOS Klinikum Wuppertal GmbH
Wuppertal, Germany

Study Contact

Instytut Centrum Zdrowia Matki Polki
Lodz, Poland

Study Contact

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw, Poland

Study Contact

Centrum Zdrowia MDM
Warszawa, Poland